TRIM proteins are involved in many diseases and clinically relevant processes emphasizing the need for deep knowledge of TRIM proteins mechanism of action in order to design and develop targeting strategies. The ultimate goal of TRIM-NET is determining how TRIM proteins contribute to disease and how we can use this information to develop novel therapeutics for TRIM family members that are involved in common and rare pathologies, thus heavily impacting on public health.
Marie Skłodowska-Curie Action - Innovative Training Networks
Starting date: January 1, 2019
Closing date: December 31, 2022
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie grant agreement No 813599, call H2020-MSCA-ITN-2018 - Innovative Training Networks 2018.